Clinical trial Recruiting at 1 site Observational Ages Any age to 18

Using atropine eyedrops to treat myopia in children

Official title: Atropine 0.01% Eyedrops for Evolutive Myopia Treatment in Children. MYOPSTOP

Run by Centre Hospitalier Universitaire de Saint Etienne · NCT04252989 · Data updated 2026-11-12

This study tests whether daily atropine eyedrops can help children with worsening nearsightedness see better.

More Myopia trials

Quick facts

Study typeObservational
AgesAny age to 18 Years
SexAll
Enrollment50 (estimated)
SponsorCentre Hospitalier Universitaire de Saint Etienne
Academic / other
Locations1 site (Saint-Etienne)
StatusRecruiting
StartedDecember 18, 2019
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedMarch 18, 2025
Trial IDNCT04252989 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children with active myopia who are being treated with atropine 0.01% eyedrops.

Probably not a fit

Patients who may not benefit from this study include those who are non-compliant with the treatment regimen.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the treatment of evolutive myopia in children using atropine 0.01% eyedrops, administered once daily. The study aims to collect data on the effectiveness of this treatment, which has shown promising results in clinical practice since 2017 at the hospital of Saint-Etienne. By building a comprehensive database, the investigators hope to publish their findings and share their experiences regarding the treatment of myopia in the French pediatric population.

Why it matters

Potential benefit: If successful, this treatment could significantly slow the progression of myopia in children, potentially reducing the risk of severe vision complications later in life.

How similar studies have gone: Other studies have shown promising results with atropine treatment for myopia, indicating that this approach is supported by existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children with active myopia treated with ATROPINE 0.01% eye drops
* patient affiliated with a social security organization
* agreement of both parents

Exclusion Criteria:

* non compliance with treatment

Where it's running

  • CHU de Saint Etienne
    Saint-Etienne, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.